Sr. Principal Process Engineer - Oligonucleotides (NOT REMOTE - NEW SITE)

Chester, Maryland, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Candidates must possess a Bachelor's Degree in Process, Chemical, Biochemical Engineering, or a related STEM discipline, with a minimum of 5 years of experience in API Manufacturing Unit Operations. Experience with API chemical synthesis, biotech operations, and chromatography is preferred, along with a strong understanding of GMP production environments and chemical engineering principles. The ability to work independently and collaboratively within cross-functional teams, coupled with coaching and mentoring skills for technical development, is essential. The role requires a proactive approach to identifying and implementing improvements and flexibility to adapt to evolving business needs. This is a full-time, on-site position requiring relocation to the new site area.

Responsibilities

The Senior Principal Process Engineer will provide technical leadership for API production operations, mentoring process engineers, and sustaining process knowledge. Key responsibilities include supporting and reviewing root cause analyses, identifying and addressing process knowledge gaps, and capturing critical process knowledge such as material and energy balances. The role also involves maintaining process safety, ensuring equipment qualification aligns with intended use, integrating modeling and simulation for process enhancement, and driving continuous improvement initiatives. Additionally, the engineer will lead or support tech transfers, oversee the development of user requirements and design reviews, and guide return-to-service protocols following equipment interventions.

Skills

Oligonucleotide API supply

Process engineering

Statistical methods

Root cause analysis

GMP manufacturing

Process optimization

Equipment qualification

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free